In one paragraphArticle in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
16 authors.
Gaukhar M YusubalievaFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.ORCID 0000-0003-3056-4889 Daria A ChudakovaFederal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.ORCID 0000-0002-9354-6824 Polina G ShirokikhFederal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.
Diana V YuzhakovaFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
Elena B KiselevaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia.ORCID 0000-0003-4769-417X Daria A SachkovaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia.ORCID 0009-0004-0401-5688 Varvara V DudenkovaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, 603005 Nizhny Novgorod, Russia.ORCID 0000-0001-6761-5585 Daria P KirsovaFederal Center for Brain and Neurotechnologies, Federal Medical and Biological Agency of Russia, 117513 Moscow, Russia.ORCID 0009-0000-6596-5370 Maria S MyzinaFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
Elvira P YanyshevaFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.ORCID 0009-0007-0032-3474 Alexander V PanovFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
Natalia F ZakirovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.ORCID 0000-0001-9704-6977 Anastasia V PoteryakhinaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.
Alexander S SemikhinFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
Alexander A KalinkinFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.
Vladimir P BaklaushevFederal Research and Clinical Center of Specialized Medical Care and Medical Technologies, Federal Medical and Biological Agency of Russia, 115682 Moscow, Russia.ORCID 0000-0003-1039-4245 Funding
This research was funded by the Russian Science Foundation, grant No. 22-64-00057. Parts of work focused on TIL immunotherapy of GBM were funded by FMBA of Russia. No. 22-64-00057
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
animal modelscell therapyFluorescence lifetime imaging microscopy (FLIM)glioblastomaimmunotherapyoncolytic virusesoptical coherence tomography (OCT)TILs
Identifiers
PMID41462989
PMCPMC12730700
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390